Tuesday, January 26, 2021
Literary Reviews
  • Home
  • OUR BOOK SHOP
    • Erotic Novels
    • BEST SELLING BOOKS
    • Science Fiction Books
    • Business and Management
    • Computing and IT
    • Cooking
    • Education
    • Religion & Spirituality
    • Self Help
    • Teens & Young Adults
  • Literary Review
  • Literature
  • Book Writing
  • Kindle Publishing
  • Romantic
  • Science Fiction
  • Cooking
  • MORE
    • Erotic
    • Mysteries, Thrillers
    • Literary Themes
    • Business and Management
    • Literary Agents
    • Literary Devices
    • New Books
    • Self Help
    • Teens & Young Adults Novels
    • Computing and IT
    • Education
    • Religion & Spirituality Novels
No Result
View All Result
Literary Reviews
Home Business and Management

Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conference Nasdaq:ITRM

admin by admin
January 7, 2021
in Business and Management
0
Iterum Therapeutics to Participate in H.C. Wainwright BioConnect Virtual Conference Nasdaq:ITRM
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter


DUBLIN, Ireland and CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that management will participate in the H.C. Wainwright BioConnect Conference being held virtually from January 11-14, 2021. Corey Fishman, Chief Executive Officer, will provide a company overview and business update. The Company’s presentation will be available on-demand through the H.C. Wainwright conference portal, beginning on Monday, January 11th at 6:00 a.m. Eastern Time.

The presentation may also be accessed by visiting the “Investors” section of the Company’s website under the “Events and Presentations” tab at www.iterumtx.com.

Related posts

Kobe Bryant’s business empire remains strong after his death

Kobe Bryant’s business empire remains strong after his death

January 25, 2021
Big data helps put numbers on sustainability

Big data helps put numbers on sustainability

January 25, 2021

About Iterum Therapeutics plc

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications.

Forward-Looking Statements

This press release contains forward-looking statements. These forward-looking statements include, without limitation, statements regarding the development, therapeutic and market potential of sulopenem. In some cases, forward-looking statements can be identified by words such as “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “would,” “will,” “future,” “potential” or the negative of these or similar terms and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include all matters that are not historical facts. Actual future results may be materially different from what is expected due to factors largely outside the Company’s control, including the uncertainties inherent in the initiation and conduct of clinical trials, availability and timing of data from clinical trials, changes in regulatory requirements or decisions of regulatory authorities, the timing of approval of any submission, changes in public policy or legislation, commercialization plans and timelines, if oral sulopenem is approved, the actions of third-party clinical research organizations, suppliers and manufacturers, risks regarding intellectual property rights in product candidates and the ability to defend and enforce any such intellectual property rights, the accuracy of the Company’s expectations regarding how far into the future the Company’s cash on hand will fund the Company’s ongoing operations, the sufficiency of the Company’s cash resources and the Company’s ability to continue as a going concern, the impact of COVID-19 and related responsive measures thereto, the Company’s ability to maintain listing on the Nasdaq Capital Market, risks and uncertainties concerning the outcome, impact, effects and results of the Company’s evaluation of corporate, organizational, strategic, financial and financing alternatives, including the terms, timing, structure, value, benefits and costs of any corporate, organizational, strategic, financial or financing alternative and the Company’s ability to complete one at all, the price of the Company’s securities and other factors discussed under the caption “Risk Factors” in its most recently filed Quarterly Report on Form 10-Q, and other documents filed with the SEC from time to time. Forward-looking statements represent the Company’s beliefs and assumptions only as of the date of this press release. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

Investor Contact:
Judy Matthews
Chief Financial Officer
312-778-6073
IR@iterumtx.com

Tags: BioConnectconferenceIterumNasdaqITRMparticipateTherapeuticsVirtualWainwright
Previous Post

Chatham author’s new novel takes on a corrupt politician

Next Post

I cook, I work out, I watch movies: how the pandemic gave me my time back | US news

Next Post

I cook, I work out, I watch movies: how the pandemic gave me my time back | US news

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Author’s new book Saturn receives a warm literary welcome

Author’s new book Saturn receives a warm literary welcome

7 months ago
JOSEPHINE DECKER with Madeline Whittle – The Brooklyn Rail

JOSEPHINE DECKER with Madeline Whittle – The Brooklyn Rail

6 months ago
In new book, Catholic woman shares struggle to understand her sexuality

In new book, Catholic woman shares struggle to understand her sexuality

4 months ago
Five of the best romantic novels for young adults

Teenage voices, wokeness, race — what’s new in young adult fiction?

5 months ago

Products

  • Self-Care for the Real World: Practical self-care advice for everyday life £12.65
  • Disgrace: An erotic BDSM contemporary romance series (The Disgrace Trilogy Book 1) £2.99
  • Nadiya Hussain – Time to Eat: Delicious, time-saving meals using simple store-cupboard ingredients £13.40
  • Sweet Little Lies: The Number One Bestseller £6.55
  • Salt, Fat, Acid, Heat: Mastering the Elements of Good Cooking £24.14

BROWSE BY CATEGORIES

  • Book Writing
  • Business and Management
  • Computing and IT
  • Cooking Books
  • Education
  • Erotic
  • Kindle Publishing
  • Literary Agents
  • Literary Devices
  • Literary Review
  • Literary Themes
  • Literature
  • Mysteries, Thrillers & Suspense
  • New Books
  • Religion & Spirituality
  • Romantic Novels
  • Science Fiction
  • Self Help

RELATED PRODUCTS

  • Pines: 1 (Wayward Pines) £8.99
  • Marriage is Murder?: A Cozy Historical Murder Mystery (The Posie Parker Mystery Series Book 9) £0.99
  • BTEC Level 3 National IT Student Book 2 (BTEC National for IT Practitioners) £30.56
  • Lockdown: the crime thriller that predicted a world in quarantine £5.00
  • The Invincible Company: How to Constantly Reinvent Your Organization with Inspiration From the World′s Best Business… £16.49

PRODUCT CATEGORIES

  • Best Selling Books
  • Erotic
  • Science Fiction Books
  • Cooking
  • Business and Management
  • Education
  • Computing and IT
  • Religion & Spirituality
  • Teens & Young Adults
  • Self Help
  • Mysteries, Thrillers & Suspense
  • Romance Books
Literary Reviews

Follow us on social media:

Recent News

  • Israeli romantic novel translated into Arabic for the first time – Middle East Monitor
  • Spotify Tests Audiobooks With ‘Frankenstein,’ ‘Jane Eyre’ and Other Literary Classics (Exclusive)
  • Lust From Beyond Release Date Delayed to Late February 2021

Category

  • Book Writing
  • Business and Management
  • Computing and IT
  • Cooking Books
  • Education
  • Erotic
  • Kindle Publishing
  • Literary Agents
  • Literary Devices
  • Literary Review
  • Literary Themes
  • Literature
  • Mysteries, Thrillers & Suspense
  • New Books
  • Religion & Spirituality
  • Romantic Novels
  • Science Fiction
  • Self Help

Recent News

Israeli romantic novel translated into Arabic for the first time – Middle East Monitor

Israeli romantic novel translated into Arabic for the first time – Middle East Monitor

January 25, 2021
Spotify Tests Audiobooks With ‘Frankenstein,’ ‘Jane Eyre’ and Other Literary Classics (Exclusive)

Spotify Tests Audiobooks With ‘Frankenstein,’ ‘Jane Eyre’ and Other Literary Classics (Exclusive)

January 25, 2021
  • Home
  • OUR BOOK SHOP
  • Literary Review
  • Literature
  • Book Writing
  • Kindle Publishing
  • Romantic
  • Science Fiction
  • Cooking
  • MORE

© 2020 literaryreviews

No Result
View All Result
  • Home
  • OUR BOOK SHOP
    • Erotic Novels
    • BEST SELLING BOOKS
    • Science Fiction Books
    • Business and Management
    • Computing and IT
    • Cooking
    • Education
    • Religion & Spirituality
    • Self Help
    • Teens & Young Adults
  • Literary Review
  • Literature
  • Book Writing
  • Kindle Publishing
  • Romantic
  • Science Fiction
  • Cooking
  • MORE
    • Erotic
    • Mysteries, Thrillers
    • Literary Themes
    • Business and Management
    • Literary Agents
    • Literary Devices
    • New Books
    • Self Help
    • Teens & Young Adults Novels
    • Computing and IT
    • Education
    • Religion & Spirituality Novels

© 2020 literaryreviews

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In